HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307990 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Izzy Chiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, United States of America. Hauptthemen laut MEDLINE: Hepatitis C, HIV Infections, Coinfection, Transgender Persons. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Mental Health, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Abstract (Originalsprache)
Background
Transgender women (hereafter “trans women”) face social marginalization, stigma, and discrimination and experience a high burden of HIV. More recently, trans women have been identified as having a high risk for hepatitis C (HCV) infection. The interaction between these two diseases and the risks for HIV/HCV co-infection among trans women are understudied.
Objective
To characterize epidemiological, behavioral, and socio-structural interactions between HIV and HCV infections among trans women.
Methods
This cross-sectional study examined data from a community-based survey of trans women in San Francisco recruited through respondent-driven sampling (RDS) in 2019/2020. Face-to-face interviews collected data on demographics, medical history, drug injection practices, sexual behavior, and socio-structural factors (e.g., poverty, housing insecurity, incarceration, social support). HIV and HCV antibodies were detected using oral fluid rapid tests and prior diagnosis and treatment were collected by self-report. Blood specimens were collected to confirm antibodies using ELISA. Multinomial logistic regression analysis characterized factors associated with HIV infection alone, HCV infection alone, and HIV/HCV co-infection compared to neither infection.
Results
Among 201 trans women recruited, HIV prevalence was 42.3%; HCV infection by history or current seroprevalence was 28.9%; evidence for both HIV and HCV infection was present for 18.9%. Two-thirds of trans women (67.2%) had been incarcerated; 30.8% had ever injected drugs. History of injection drug use and receiving emotional support from family were factors found in common for HIV infection, HCV infection, and HIV/HCV co-infection compared to no infection. Having a sexual partner who injects drugs was associated with HIV infection alone. Not lacking care due to cost and older age were associated with co-infection. Older age was also associated with HCV infection. Of trans women with HIV infection, 91.8% had accessed HIV care, whereas only 62% with HCV had accessed some form of care.
Conclusions
Our study found high levels of HIV, HCV, and HIV/HCV co-infection among trans women in San Francisco. We found common associations between HIV and HCV through injection practices and emotional support, but having a sexual partner who injects drugs was not associated with HCV infection alone or co-infection. We note a substantial gap in the treatment of HCV for trans women, including those in HIV care, that needs to be urgently addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, United States of America.
- Center for Public Health Research, San Francisco Department of Public Health, San Francisco, CA, United States of America.
- University of California Berkeley, Berkeley, CA, United States of America.
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States of America.
- Department of Health, Society, & Behavior, University of California, Irvine, Irvine, CA, United States of America.
ORCID-Profile: Izzy Chiu, Dillon Trujillo, Kelly D Taylor
Förderung
- National Institute of Mental Health
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Zitieren
APA
Chiu, I., Cano, D., Leathers, M., Turner, C. M., Trujillo, D., Sicro, S., Arayasirikul, S., Taylor, K. D., Wilson, E. C., & McFarland, W. (2024). HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020. PLOS ONE. https://doi.org/10.1371/journal.pone.0307990
Vancouver
Chiu I, Cano D, Leathers M, Turner CM, Trujillo D, Sicro S, et al. HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020. PLOS ONE. 2024. doi:10.1371/journal.pone.0307990
BibTeX
@article{Chiu2024,
author = {Chiu, Izzy and Cano, Damiana and Leathers, Matisse and Turner, Caitlin M and Trujillo, Dillon and Sicro, Sofia and Arayasirikul, Sean and Taylor, Kelly D and Wilson, Erin C and McFarland, Willi},
title = {HIV and hepatitis C virus infection and co-infection among trans women in San Francisco, 2020},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307990}
}
EUVIMED